Acadia Pharmaceuticals ACAD announced that it has signed an exclusive worldwide license agreement with Saniona, a Denmark-based clinical-stage biopharmaceutical company, to develop and commercialize ...

Adjusted Total Revenues (Q4 2025): $298 million, up 16% year-over-year. Annual Adjusted Revenues (2025): $1.08 billion, representing 14% growth from the prior year. Adjusted New Placid Net Sales (Q4 ...

View ACADIA Pharmaceuticals Inc. ACAD stock quote prices, financial information, real-time forecasts, and company news from CNN.

Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably already heard of GSK (GSK) and Acadia Pharmaceuticals (ACAD). But which of these two stocks is more ...

Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Kamada (KMDA) or Acadia Pharmaceuticals (ACAD). But which of these two stocks is more ...

Fintel reports that on March 25, 2026, B of A Securities upgraded their outlook for ACADIA Pharmaceuticals (NasdaqGS:ACAD) ...